{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-024811","form_type":"8-K","ticker":"FHTX","cik":"0001822462","company_name":"Foghorn Therapeutics Inc.","filed_at":"2024-05-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.395868+00:00","generated_at":"2026-06-01T09:19:36.244490+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Foghorn Therapeutics furnishes investor presentation; no specific material updates disclosed in exhibit","bullets":["Investor presentation title: 'Unique biology, Precision therapeutics, Broad impact' — no additional content provided.","No financial results, pipeline updates, or guidance changes are included in this filing.","The filing does not contain any material new information beyond the existence of the presentation."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-024811","json":"https://secwatch.observer/filing/0001628280-24-024811.json","markdown":"https://secwatch.observer/filing/0001628280-24-024811.md","text":"https://secwatch.observer/filing/0001628280-24-024811.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1822462/000162828024024811/0001628280-24-024811-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1822462/000162828024024811/fhtx-20240523.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T09:19:36.244490+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}